Status:

COMPLETED

Effects of High Dietary Fiber Supplementation in Diabetic Chronic Kidney Disease

Lead Sponsor:

University of Utah

Conditions:

Kidney Disease

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

Loss of kidney function results in accumulation in the blood of molecules that are either excreted or metabolized by the kidney. Collectively, these molecules are termed Uremic Retention Molecules (UR...

Eligibility Criteria

Inclusion

  • Patients with or without diabetes and Stage 1 or 2 CKD (estimated Glomerular Filtration Rate \> 60 mL/min/1.73 m2) with urine dipstick positive for protein or urinary albumin/ creatinine \> 30 mg/g of creatinine; or
  • Stage 3 or 4 CKD (estimated Glomerular Filtration Rate \< 60 to 15 mL/min/1.73 m2).

Exclusion

  • Pregnant women
  • Prisoners
  • Bowel obstruction
  • Enrolled in other interventional studies.

Key Trial Info

Start Date :

June 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2016

Estimated Enrollment :

44 Patients enrolled

Trial Details

Trial ID

NCT01838330

Start Date

June 1 2012

End Date

January 1 2016

Last Update

August 11 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Utah nephrology clinics, the internal medicine and endocrinology clinics

Salt Lake City, Utah, United States, 84112